Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AceP-D: MPI for Atypical Chest Pain in Diabetes
NCT00162344Phase 4Completed
- Sponsor
- Lantheus Holdings, Inc.
- Start
- Dec 2003
- Primary completion
- Dec 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of technetium-99m sestamibi in coronary artery disease (CAD), sponsored by Lantheus Holdings, Inc.. Started Dec 2003; status: completed.
02
Drugs
technetium-99m sestamibi
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00162344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00162344.